CME|Analyst Targets
CME|Company Info
CME|Insider Trading
CME|Fundamentals
CME|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'26 | $3.06 | - | - |
| Q3'26 | $3.02 | $3.02 | +0.0% |
| Q2'26 | $2.91 | $2.99 | +2.8% |
| Q1'26 | $3.12 | $3.36 | +7.8% |
| Q4'25 | $2.77 | $2.77 | -0.0% |
| Q3'25 | $2.63 | $2.68 | +2.0% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'26 | $1.8B | - | - |
| Q3'26 | $1.7B | $1.7B | +0.4% |
| Q2'26 | $1.7B | $1.7B | +0.2% |
| Q1'26 | $1.8B | $1.9B | +5.8% |
| Q4'25 | $1.7B | $1.6B | -1.1% |
| Q3'25 | - | $1.5B | - |
CME|Monthly Returns
Market Data
CME Stock Snapshot
- Market cap
- 110.99B
- P/E ratio
- 25.1
- Day range
- $301.40 – $310.98
- News sentiment
- 46/100 · Neutral
- Analyst target
- $317.06 (+3.3%)
- Consensus
- Buy · 23 analysts
CME Group Inc. is consolidating: price is in the upper part of its 52-week range without a decisive push either way. Sector peers are worth watching - large caps in Financial Services tend to move together on rotation.
Behaviour On Record
What CME's own history says about today's numbers
- Realized volatility (21d)
- 25.8% 82nd pct
- Below its peak
- -5.9%
- vs 200-day average
- +9.8%
- Up days (1y)
- 56%
CME Group Inc. is currently running 25.8% annualised volatility over the last 21 sessions. Measured against CME's own 13 years of daily returns rather than a market-wide average, that is the 82nd percentile — elevated for this stock, against a typical reading of 18.9%.
CME is trading -5.9% below its running peak. Across 13 full years on file, its median worst-drawdown-in-a-year was -13.4%, and the deepest was -37.6% in 2020. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.
Price sits +9.8% from its 200-day moving average. Against every other day in its history, that gap ranks at the 70th percentile — a somewhat wider gap than its own norm. Over the past year CME closed higher on 56% of sessions, and it is currently 1 session into a rising streak.
On November specifically: over 13 years of records, CME finished the month higher 12 of 13 times, with a median return of +3.5% and an average of +5.7%. Its strongest month historically has been November at +5.7% on average, its weakest March at -3.0%.
Overnight risk is measurable too: CME has opened more than 2% away from the prior close in 72 of 3,267 sessions (2.2% of the time), with the largest gaps running +4.9% and -7.8%.
Across the last 4 dated reports on file, CME moved an average of 1.6% in the session after earnings, closing higher 4 of those 4 times, with a median move of +1.4% and a largest of +3.6%.
All figures computed from 3,268 daily closes between 2013-11-06 and 2026-11-04, split-adjusted, recomputed daily. Percentiles are against CME's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of CME's sector?
CME Group Inc. sits in the Financials sector, currently ranked 6th of 12 GICS sectors by relative-strength rotation score (leading).
- Sector rank
- #6 of 12
- Sector state
- Leading
- Sector rotation score
- 45
Analyst Consensus Estimates
What do analysts expect CME to earn?
Analysts expect CME Group Inc. to earn $12.40 per share in the fiscal year ending Dec 2026 and $14.95 in the fiscal year ending Dec 2029, from 3 estimates. These are analyst forecasts, not company guidance, and later years rest on fewer analysts.
Revenue marked ~ is our calculation from the EPS estimate, not analyst consensus.
Analyst Rating Changes
Are analysts turning bullish or bearish on CME?
UBS most recently reiterated its rating on CME Group Inc. to Neutral on Oct 22, 2026 with a price target of $310 (from $270). Over the last 90 days, coverage has run 1 upgrade against 1 downgrade, a net mixed lean.
- Latest action
- UBS: Neutral
- 90-day upgrades
- 1
- 90-day downgrades
- 1
- Net rating momentum
- 0
Corporate Stakes
Which companies own a stake in CME?
Alphabet Inc. reports a stake in CME Group Inc. on SEC Form 13F: 3.5M shares, about 0.96% of the company, worth $769.4M at the end of Q2 2026. At today's price that stake is worth $1.07B, about 0.03% of GOOGL's own market value.
- Holder
- GOOGL
- Shares held
- 3.5M
- Stake
- 0.96%
- Value
- $769.4M
Form 13F lists US-listed shares held at quarter-end and is filed up to 45 days later. Stakes in private companies are not on it. Value now and Change put those same shares, adjusted for any stock split, at today's price against their reported quarter-end value, so they do not reflect buying or selling since.
Earnings Release, Scored
What did CME Group Inc.'s latest earnings release say?
Most important lines
- 1
"Our average daily volume reached 29.4 million contracts, the highest Q3 ADV on record.
New this quarter - 2
Q3 2026 average daily volume (ADV) climbed to a third-quarter record of 29.4 million contracts, and non-U.S. ADV reached a third-quarter high of 9 million contracts.
New this quarter - 3
With double-digit volume growth across all six asset classes, Q3 was our second highest quarter ever for revenue and adjusted net income.
New this quarter
Peers & ETF holders
CME peers & ETF holders
Financial Data & Stock ExchangesMarket cap · today
News & sentiment
What is the news saying about CME?
CME rose 13.3% over the month to Nov 6. News tone held between 40 and 76 from Oct 6 to Oct 19, then dropped to 54 on Oct 20.
- Oct 14 +2.7%same day: CME Group (CME) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Oct 22 +3.6%same day: CME CEO Says Crypto Perps Are Swaps While Suing CFTC Over Their Approval
- Oct 27 -4.5%same day: CME Group (CME) Eyes European Dairy With New Futures And Options
Technical analysis
How strong is CME's momentum right now?
On the daily chart CME ranks at the 44th percentile for momentum against 1,060 stocks and ETFs, a neutral reading.
Institutional ownership
Are big funds buying or selling CME?
118 of the 233 tracked managers added to CME in their latest 13F and 112 trimmed. Together they own 70.2% of the company, worth $56.8B. BlackRock and Vanguard Capital Management alone hold 15.0%.
- 1BlackRock, Inc.8.46%$6.7B positionTrimmed 2.8% last quarter
- $5.2B positionAdded 1.3% last quarter
- 3State Street Corp4.52%$3.6B positionAdded 1.8% last quarter
- 4Morgan Stanley2.69%$2.1B positionAdded 3.4% last quarter
- $2.0B positionAdded 1.4% last quarter
- $2.0B positionAdded 1.5% last quarter
- 7Capital World Investors1.89%$1.5B positionTrimmed 1.6% last quarter
- 8JPMorgan Chase & Co1.60%$1.3B positionTrimmed 52.8% last quarter
- 9Sanders Capital, LLC1.40%$1.3B positionTrimmed 0.2% last quarter
- 10Norges Bank1.33%$1.1B positionTrimmed 13.6% last quarter
Congressional trading
Is Congress trading CME?
9 members of Congress disclosed 17 CME trades between Jul 23, 2014 and Jun 16, 2026: 9 buys and 8 sells, about $185.0K in estimated value.
What stands out
Click one to highlight its trades in the chartDiscover more
How has CME done against its peers?
Over the six months to Nov 6, CME returned +6.5%. Of the 15 related stocks and ETFs, 8 did better, led by MA at +33.4%.
- 1MAMastercard Incorporatedup 33.4%+26.9 pts
- 2PYPLPayPal Holdings, Inc.up 28.6%+22.1 pts
- 3NDAQNasdaq, Inc.up 19.8%+13.3 pts
- 4SPGIS&P Global Inc.up 16.0%+9.5 pts
- 5MCOMoody's Corporationup 12.9%+6.4 pts
- 6ICEIntercontinental Exchange, Inc.up 12.2%+5.8 pts
- 7XLFFinancial Select Sector SPDR Fundup 10.9%+4.4 pts
- 8MSCIMSCI Inc.up 9.8%+3.3 pts
- 9CMEThis stockup 6.5%
- 16PAYPPayPay Corporationdown 29.7%−36.2 pts